Targeted GvHD prophylaxis: Vedolizumab in the GvHD prevention regime with post-transplant cyclophophospamide, abatacept, calceneurin inhibitors in adults with hematologic disease: Result prospective study
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Artur Yunusov, Iuliia Oleinik, Anton Subora, Irina Zikunova, Victoria Skurikhina, Sergey Shalaev, Matvei Bulusov, Evdokia Urnova, Michael Maschan, Vadim Ptushkin
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108448509
Cites:
Cited by:
Related to: